Loading...
Efficient correction of Duchenne muscular dystrophy mutations by SpCas9 and dual gRNAs
CRISPR gene therapy is one promising approach for treatment of Duchenne muscular dystrophy (DMD), which is caused by a large spectrum of mutations in the dystrophin gene. To broaden CRISPR gene editing strategies for DMD treatment, we report the efficient restoration of dystrophin expression in indu...
Na minha lista:
| Udgivet i: | Mol Ther Nucleic Acids |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Gene & Cell Therapy
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8039775/ https://ncbi.nlm.nih.gov/pubmed/33868784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2021.03.005 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|